Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 17.08
(0.47%)
CNY 17.08
(0.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.1 Billion CNY | 18.44% |
| 2022 | 930.91 Million CNY | -30.29% |
| 2021 | 1.33 Billion CNY | 178.15% |
| 2020 | 480.13 Million CNY | 272.49% |
| 2019 | 128.9 Million CNY | -76.93% |
| 2018 | 558.73 Million CNY | -49.76% |
| 2017 | 1.11 Billion CNY | 881.28% |
| 2016 | 113.34 Million CNY | 1832.02% |
| 2015 | 5.86 Million CNY | -87.31% |
| 2014 | 46.22 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 443.16 Million CNY | -19.54% |
| 2024 Q1 | 1 Billion CNY | -9.12% |
| 2024 Q2 | 976.58 Million CNY | -10.21% |
| 2023 Q3 | 1.53 Billion CNY | 19.15% |
| 2023 Q2 | 1.28 Billion CNY | 40.01% |
| 2023 Q1 | 917.67 Million CNY | -1.42% |
| 2023 FY | 1.1 Billion CNY | 18.44% |
| 2023 Q4 | 1.1 Billion CNY | -27.97% |
| 2022 Q4 | 930.91 Million CNY | -32.01% |
| 2022 Q2 | 1.24 Billion CNY | -6.99% |
| 2022 FY | 930.91 Million CNY | -30.29% |
| 2022 Q1 | 1.33 Billion CNY | 0.03% |
| 2022 Q3 | 1.36 Billion CNY | 10.2% |
| 2021 FY | 1.33 Billion CNY | 178.15% |
| 2021 Q1 | 785.07 Million CNY | 63.51% |
| 2021 Q2 | 792.32 Million CNY | 0.92% |
| 2021 Q3 | 1.22 Billion CNY | 54.33% |
| 2021 Q4 | 1.33 Billion CNY | 9.22% |
| 2020 Q4 | 480.13 Million CNY | 7.76% |
| 2020 Q1 | 127.52 Million CNY | -1.07% |
| 2020 Q2 | 558.59 Million CNY | 338.03% |
| 2020 FY | 480.13 Million CNY | 272.49% |
| 2020 Q3 | 445.58 Million CNY | -20.23% |
| 2019 Q4 | 128.9 Million CNY | -69.46% |
| 2019 Q2 | 501.9 Million CNY | 0.04% |
| 2019 Q3 | 422.12 Million CNY | -15.9% |
| 2019 FY | 128.9 Million CNY | -76.93% |
| 2019 Q1 | 501.7 Million CNY | -10.21% |
| 2018 Q2 | 1.1 Billion CNY | -0.77% |
| 2018 FY | 558.73 Million CNY | -49.76% |
| 2018 Q4 | 558.73 Million CNY | -1.83% |
| 2018 Q3 | 569.14 Million CNY | -48.45% |
| 2018 Q1 | 1.11 Billion CNY | 0.04% |
| 2017 Q2 | 178.96 Million CNY | 60.36% |
| 2017 FY | 1.11 Billion CNY | 881.28% |
| 2017 Q1 | 111.6 Million CNY | -1.53% |
| 2017 Q4 | 1.11 Billion CNY | 22.59% |
| 2017 Q3 | 907.26 Million CNY | 406.94% |
| 2016 Q1 | 5.73 Million CNY | -2.19% |
| 2016 Q4 | 113.34 Million CNY | 1970.13% |
| 2016 Q3 | 5.47 Million CNY | -2.36% |
| 2016 Q2 | 5.6 Million CNY | -2.27% |
| 2016 FY | 113.34 Million CNY | 1832.02% |
| 2015 FY | 5.86 Million CNY | -87.31% |
| 2015 Q1 | 38.17 Million CNY | -17.41% |
| 2015 Q2 | 48.09 Million CNY | 25.97% |
| 2015 Q3 | 38.7 Million CNY | -19.53% |
| 2015 Q4 | 5.86 Million CNY | -84.84% |
| 2014 FY | 46.22 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | 17.41 Million CNY | 0.0% |
| 2014 Q4 | 46.22 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 41.92 Million CNY | -2530.016% |
| WuXi AppTec Co., Ltd. | 687.01 Million CNY | -60.494% |
| Autobio Diagnostics Co., Ltd. | 24.63 Million CNY | -4375.717% |
| Thalys Medical Technology Group Inc. | 596.75 Million CNY | -84.77% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 267.61 Million CNY | -312.023% |
| Chemclin Diagnostics Co., Ltd. | 227.94 Million CNY | -383.715% |